Revvity, Eonis System
Multiplexing of SMA, SCID and XLA screening can now be done in one assay utilizing Real-Time PCR technology, without increasing daily hands-on workload and complexity. This will provide a future-proof solution for cost-efficiently obtaining additional disorder information.
Catalog Number: EONISSYSTEM
Send an RFQ.
Category
